(4S-(4alpha,5beta(S')))-5-(1-Hydroxy-2,4,6-heptatriynyl)-2-oxo-1,3-dioxolane-4-heptanoic acid

(4S-(4alpha,5beta(S')))-5-(1-Hydroxy-2,4,6-heptatriynyl)-2-oxo-1,3-dioxolane-4-heptanoic acid Struktur
115216-83-6
CAS-Nr.
115216-83-6
Englisch Name:
(4S-(4alpha,5beta(S')))-5-(1-Hydroxy-2,4,6-heptatriynyl)-2-oxo-1,3-dioxolane-4-heptanoic acid
Synonyma:
EV-22;L-660631;Sch 31828;Antibiotic EV-22;Antibiotic L-660631;(4S,5S)-5α-[(R)-1-Hydroxy-2,4,6-heptatriynyl]-2-oxo-1,3-dioxolane-4β-heptanoic acid;1,3-Dioxolane-4-heptanoic acid, 5-[(1R)-1-hydroxy-2,4,6-heptatriynyl]-2-oxo-, (4S,5S)- (9CI);(4S-(4alpha,5beta(S')))-5-(1-Hydroxy-2,4,6-heptatriynyl)-2-oxo-1,3-dioxolane-4-heptanoic acid
CBNumber:
CB11119810
Summenformel:
C17H18O6
Molgewicht:
318.32
MOL-Datei:
115216-83-6.mol

(4S-(4alpha,5beta(S')))-5-(1-Hydroxy-2,4,6-heptatriynyl)-2-oxo-1,3-dioxolane-4-heptanoic acid Eigenschaften

Sicherheit

(4S-(4alpha,5beta(S')))-5-(1-Hydroxy-2,4,6-heptatriynyl)-2-oxo-1,3-dioxolane-4-heptanoic acid Chemische Eigenschaften,Einsatz,Produktion Methoden

(4S-(4alpha,5beta(S')))-5-(1-Hydroxy-2,4,6-heptatriynyl)-2-oxo-1,3-dioxolane-4-heptanoic acid Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


(4S-(4alpha,5beta(S')))-5-(1-Hydroxy-2,4,6-heptatriynyl)-2-oxo-1,3-dioxolane-4-heptanoic acid Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 3)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 19892 58
BOC Sciences 1-631-485-4226; 16314854226
info@bocsci.com United States 14059 65

  • (4S-(4alpha,5beta(S')))-5-(1-Hydroxy-2,4,6-heptatriynyl)-2-oxo-1,3-dioxolane-4-heptanoic acid
  • Sch 31828
  • (4S,5S)-5α-[(R)-1-Hydroxy-2,4,6-heptatriynyl]-2-oxo-1,3-dioxolane-4β-heptanoic acid
  • Antibiotic EV-22
  • Antibiotic L-660631
  • EV-22
  • L-660631
  • 1,3-Dioxolane-4-heptanoic acid, 5-[(1R)-1-hydroxy-2,4,6-heptatriynyl]-2-oxo-, (4S,5S)- (9CI)
  • 115216-83-6
Copyright 2019 © ChemicalBook. All rights reserved